Meiji Holdings Co., Ltd. · TSE:2269
Meiji — H1 FYE March 2014 Earnings Presentation
25 slides from Meiji's earnings presentation, Nov 19, 2013
Slide 1: Financial Results for the First Half of FYE March 2014
Financial Results - For the First Half of FYE March 2014 - 2013.11.19 Nov.19, 2013 Copyright © 2013 Meiji Holdings Co., Ltd. All rights reserved.
Slide 2: Contents
Contents 1. Our Initiatives for Achieving 2. Overview of Financial Results and Forecasts Business forecasts and other forward-looking statements are based on information available at the time of the release of this presentation and reasonable assumptions made by the Company. Actual results could d
Slide 3: Medium-Term Management Plan
Medium-Term Management Plan Basic policies Targets Higher profitability and strategic investments FYE March 2015 for future growth Net sales 1.19 trillion yen 1. Strengthen and expand existing businesses (growth and priority businesses) Op. income 40.0 billion yen 2. Foster growth businesses (new an
Slide 4: Business Plan for FYE March 2014
HD Business Plan for FYE March 2014 ( Net sales: ¥ billion) Op. income: ¥ billion) Management Integration 1,400 70 Strategic investments in priority Business Reorganization and growth businesses 1,190.0 1,200 1,106.6 1,111.0 1,109.2 1,126.5 1,128.0 60 Restructuring to improve profitability 1,000
Slide 5: Food: Key Points of Strategies
Food Key Points of Strategies Structural reforms in April 2013 as follow-up to business reorganization conducted in April 2011 Restructuring to improve profitability in all businesses ( Net sales: ¥ billion) ( Op. income: ¥ billion) 1,400 70 1,200 60 1,050.0 988.8 986.3 1,001.5 996.0 1,000 50 80
Slide 6: Food: Improving Profitability in All Businesses
Food Improving Profitability in All Businesses (¥ billion) [Factors for increase] 12.0 Up ¥3.8bn - Sales growth Dairy 12.1 - Cost reduction 8.0 [Factors for decrease] 8.2 4.0 - High cost of 13.3 (1H) 14.3 (1H) raw materials Up ¥0.9bn [Factors for increase] Confectionery [Factors for decrease] - Cost
Slide 7: Dairy: Increasing Sales of Probiotics Yogurt Products
Food Dairy: Increasing in Sales of Probiotics Yogurt Products Sales and market size for yogurt products ( Our sales: ¥ billion) ( Market size: ¥ billion) Expanding business with 180 400 increased health awareness 160 350 among customers 140 300 Sales of R-1 exceeding a strong 120 250 FYE March 2
Slide 8: Dairy: Enhancing Profitability of Bulgaria Yogurt Products
Food Dairy: Enhancing Profitability of "Bulgaria" Yogurt Products New eating opportunities October 2012: Renewal of plain yogurt product lineup and aggressive marketing promotion “Bulgaria” Expand eating opportunities and target consumers Tastiness Functionality Probiotics yogurts “Gurt!” Meiji
Slide 9: Dairy: Focusing on Brand Value
Food Dairy: Focusing on Brand Value “Nofice Concerning Revision Aggressive marketing activities (storefront marketing, TV commercial, etc.) to Manufacturer's Distribution Price" (released July 23, 2013) Continue promotions in the second half Beginning October 1, prices revised to reflect incre
Slide 10: Confectionery: Improving Profitability and Focusing on Long-selling Products
Food Confectionary: Improving Profitability and focusing on long-selling products Cost reduction and low-cost operations, to offset rising raw material costs Maximization of production / demand / distribution efficiency Efficient utilization of sales promotion and advertising budgets Reducti
Slide 11: Healthcare & Nutritionals: Sales Growth and Higher Profitability
Food Healthcare&Nutritionals: Sales Growth and Higher Profitability Expand share of mainstay brands Sports nutrition / beauty supplements: Increase users through promotional activities Sports nutrition (Nutrition seminars, storefront sampling, etc.) Infant formula: Focus on our original cube-sha
Slide 12: Foster International Business - Expansion in China & Asia
Food Foster International Business - Expansion in China & Asia China Asia Dairy business [Non-consolidated] CP-Meiji (Thailand) [Equity Method Applied] From December 2013, Production & sales of drinking milk and yogurt manufacture and sales of chilled Exports to Singapore and nearby countries mi
Slide 13: Pharma: Key Points of Strategies
Pharma Key Points of Strategies Expansion of “specialty & generic" domestic Ethical Pharmaceuticals business Accelerating R&D ( Net sales: ¥ billion) ( Op. income: ¥ billion) 200 40 150 140.0 30 133.7 124.2 125.2 127.3 100 20 10.0 50 7.5 8.1 10 6.4 7.6 0 0 11.3 12.3 13.3 14.3 15.3 Plan Target 13
Slide 14: Promote Specialty & Generic Strategy
Pharma Promote "Specialty & Generic" Strategy Net Sales Sales by Business (¥ billion) (¥ billion) 160 NHI drug price 80 revisions 58.4 59.6 140 133.7 140.0 60 8.1 7.0 +4.6% 124.2 125.2 127.3 40 120 115.3 113.3 113.0 115.3 109.7 52.6 20 50.3 100 0 14.3 (1H) 15.3 (1H) 80 Ethical Pharmaceuticals Agricu
Slide 15: Accelerating R&D
Pharma Accelerating R&D R&D pipeline FYE March 2014 FYE March 2015 ME1111 [Antionychomycosis] Phase Infectious diseases (U.S.) ME1100 Arbekacin [HABP/VABP] Phase (U.S.) SME3110 Fluvoxamine [ SSRI, Pedeatriv OCD] Additional Indications Phase Central nervous system ME2136 Asenapine [Antipsychotic] Pha
Slide 16: Expand Overseas Business
Pharma Expand Overseas Business Establish a global production structure and increase overseas sales Promote MEIACT life cycle management [Russia] Partner with sales company to establish business platform [Vietnam] Establish business platform [Spain] through development of sales Establish global gene
Slide 17: Summary
HD Summary Medium-Term Management Plan Focus on higher profitability and strategic investments for future growth Minimize impact on profits by coping flexibly with economic environment Achieve operating income of 34 billion yen in FYE March 2014, and the goal of TAKE OFF 14 17 Nov.19, 2013 Cop
Slide 18: 2. Overview of Financial Results and Forecasts
2. Overview of Financial Results and Forecasts 18 Nov.19, 2013 Copyright © 2013 Meiji Holdings Co., Ltd. All rights reserved.
Slide 19: Consolidated Results: 1st Half of FYE March 2014
HD Consolidated Results: 1st Half of FYE March 2014 (¥ billion) YoY change Change vs. plan Plan Results Rate Amount Rate Amount Meiji HD Net sales 565.0 562.9 +0.3% +1.7 -0.4% -2.1 consolidated Operating income 12.0 15.8 +58.2% +5.8 +32.5% +3.8 Ordinary income 13.0 17.9 +51.8% +6.2 +37.7% +4.9 Net i
Slide 20: Analysis of Consolidated Op. Income: 1st Half
HD Analysis of Consolidated Op. Income: 1st Half (¥ billion) By segment 1st Half Results Food Pharma Other 1H of FYE March 2013 6.5 3.3 0.2 Due to increased/decreased sales +3.9 +2.8 +1.1 Cost reduction +3.7 (*1) +3.2 +0.5 Sales promotion and advertising expenses +0.9 +1.9 -1.0 Consolidated subsidia
Slide 21: Consolidated Results and Forecasts: FYE March 2014
HD Consolidated Results and Forecasts: FYE March 2014 (¥ billion) 1st half 2nd half Full-year YoY Initial Plan Revised Plan YoY Initial Plan Revised Plan YoY Results change (As of May 14) (As of Nov. 12) change (As of May 14) (As of Nov. 12) change Meiji HD +0.3% -0.0% +0.1% consolidated Net sales 5
Slide 22: Results and Forecasts by Business in Food Segment
HD Results and Forecasts by Business in Food Segment : FYE March 2014 (¥ billion) 1st half 2nd half Full-year YoY Initial Plan Revised Plan YoY Initial Plan Revised Plan YoY Results change (As of May 14) (As of Nov. 12) change (As of May 14) (As of Nov. 12) change +3.5% +2.1% +2.8% Net sales 321.2 3
Slide 23: Analysis of Consolidated Op. Income: 2nd Half
HD Analysis of Consolidated Op. Income: 2nd Half (¥ billion) By segment 2nd Half Revised Plan Food Pharma Other 2H of FYE March 2013 (Results) 15.8 12.8 3.1 -0.1 Due to increased/decreased sales +4.6 +2.3 +2.3 Cost reduction +4.0 +3.8 +0.2 Sales promotion and -4.4 -4.4 0 advertising expenses Consoli
Slide 24: Analysis of Consolidated Op. Income: FYE March 2014
HD Analysis of Consolidated Op. Income: FYE March 2014 (¥ billion) By segment Full-year Revised Plan Food Pharma Other FYE March 2013 (Results) 25.8 19.3 6.4 0 Due to increased/decreased sales +8.5 +5.1 +3.4 Cost reduction +7.7 +7.0 +0.7 Sales promotion and -6.1 -6.1 0 advertising expenses Consolida
Slide 25: Financial Strategies
HD Financial Strategies (¥ billion) FYE March 2012 FYE March 2013 FYE March 2014 FYE March 1st Half Full-year 2013-2015 Results Results Results Revised Plan Capital expenditures 38.3 37.6 21.8 51.1 161.7 Depreciation and amortization 40.8 40.8 19.8 41.0 126.5 R&D expenses 23.8 26.2 12.3 26.3 73.5 Fr
Meiji Holdings — H1 FYE March 2014 Earnings Presentation on 6ix